4-Imidazolidinehexanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)-5-methyl-2-oxo-, (4R,5S)-
4-Imidazolidinehexanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)-5-methyl-2-oxo-, (4R,5S)- Basic information
- Product Name:
- 4-Imidazolidinehexanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)-5-methyl-2-oxo-, (4R,5S)-
- Synonyms:
-
- 4-Imidazolidinehexanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)-5-methyl-2-oxo-, (4R,5S)-
- CAS:
- 2306109-91-9
- MF:
- C20H40N4O6
- MW:
- 432.55
- Mol File:
- 2306109-91-9.mol
More
Less
4-Imidazolidinehexanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)-5-methyl-2-oxo-, (4R,5S)- Chemical Properties
- Boiling point:
- 666.0±50.0 °C(Predicted)
- Density
- 1.078±0.06 g/cm3(Predicted)
- form
- Liquid
- pka
- 14.93±0.60(Predicted)
- color
- Colorless to light yellow
More
Less
4-Imidazolidinehexanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)-5-methyl-2-oxo-, (4R,5S)- Usage And Synthesis
Biological Activity
Amine-PEG4-Desthiobiotin is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].
References
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
4-Imidazolidinehexanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)-5-methyl-2-oxo-, (4R,5S)-Supplier
Xi'an Confluore Biological Technology Co., Ltd.
- Tel
- +86-156-80926068 +86-15680926068
- 1924344760@qq.com
Shanghai Haohong Pharmaceutical Co., Ltd.
- Tel
- 4008210725 4008210725
- malulu@leyan.com
Beijing Jin Ming Biotechnology Co., Ltd.
- Tel
- 010-60605840 15801484223;
- psaitong@jm-bio.com
Xian confluore Biological Technology Co., Ltd.
- Tel
- +86-15680926068 +86-15680926068
- 1924344760@confluore.cn